MenQuadfi
Nchi: Umoja wa Ulaya
Lugha: Kifinlandi
Chanzo: EMA (European Medicines Agency)
Taarifa za kipeperushi
(PIL)
13-02-2024
Tabia za bidhaa
(SPC)
13-02-2024
Ripoti ya Tathmini ya umma
(PAR)
27-11-2020
Viambatanisho vya kazi:
Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid
Inapatikana kutoka:
Sanofi Pasteur
ATC kanuni:
J07AH08
INN (Jina la Kimataifa):
meningococcal group A, C, W-135 and Y conjugate vaccine
Kundi la matibabu:
rokotteet
Eneo la matibabu:
Meningiitti, meningokokki
Matibabu dalili:
MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. The use of this vaccine should be in accordance with available official recommendations.
Bidhaa muhtasari:
Revision: 8
Idhini hali ya:
valtuutettu
Idhini ya tarehe:
2020-11-18
Taarifa za kipeperushi
504 GATEWAY TIME-OUT
Soma hati kamili
Tabia za bidhaa
504 GATEWAY TIME-OUT
Soma hati kamili
